International Journal of Management and Applied Science (IJMAS)
.
Follow Us On :
current issues
Volume-7,Issue-11  ( Nov, 2021 )
Past issues
  1. Volume-7,Issue-11  ( Nov, 2021 )
  2. Volume-7,Issue-10  ( Oct, 2021 )
  3. Volume-7,Issue-9  ( Sep, 2021 )
  4. Volume-7,Issue-8  ( Aug, 2021 )
  5. Volume-7,Issue-7  ( Jul, 2021 )
  6. Volume-7,Issue-6  ( Jun, 2021 )
  7. Volume-7,Issue-5  ( May, 2021 )
  8. Volume-7,Issue-4  ( Apr, 2021 )
  9. Volume-7, Issue-3  ( Mar, 2021 )
  10. Volume-7, Issue-2  ( Feb, 2021 )

Statistics report
Jan. 2022
Submitted Papers : 80
Accepted Papers : 10
Rejected Papers : 70
Acc. Perc : 12%
Issue Published : 93
Paper Published : 4666
No. of Authors : 9634
  Journal Paper


Paper Title :
The Comparison of the Quality of Life in Patients with Alzheimer’s Disease: before and after the Treatment Byrivastigmine in Thailand 2017

Author :Yanida Rugchoochip, Marut Tangwattanachuleporn

Article Citation :Yanida Rugchoochip ,Marut Tangwattanachuleporn , (2018 ) " The Comparison of the Quality of Life in Patients with Alzheimer’s Disease: before and after the Treatment Byrivastigmine in Thailand 2017 " , International Journal of Management and Applied Science (IJMAS) , pp. 98-101, Volume-4,Issue-1

Abstract : This research applied the Qualitative research method. The key informants in this study were the caretaker of the patients with Alzheimer’s disease in the public hospitals in Bangkok and Chonburi province. The researchers used an indepth interview approach with the 15 keys informants. Results for the overall quality of Rivastigmine, in summary, it was found that after the treatment by Rivastigmine the patients had significantly better results on their sleeping and/or emotional health development such as stress, depression, and aggressiveness. While it was also found with the significant problem from drug used such as frequent defecation and other side effects from drug such as squeamish and vomiting.Results discussion Sleeping was one of the elements that resulted on quality of life and emotional health of the elderly with Alzheimer’s disease. Taking Rivastigmine could help patients to have better sleeping in which resulted on their emotional health from reduced stress, depression, and add more liveliness including the key quality of daily life as well. However, mostly Alzheimer’s disease was found in elderly patients together with other diseases from aging thus, it was not easy to evaluate on some aspects in patients’ quality of life. Thus, the relatives and people surrounding to the patients as well as the care-taker had the major role to extend their lifetime with good quality up to another14 years although using drug may have some side effects on them. Suggestions The care-taker or relatives shall bring the patients to see the Neurological doctor and encourage them to have regular exercise, mentally stimulation and have all nutrition groups in each meal. Keywords - Quality of Life, Elderly with Alzheimer’s Disease, Rivastigmine

Type : Research paper

Published : Volume-4,Issue-1


DOIONLINE NO - IJMAS-IRAJ-DOIONLINE-10781   View Here

Copyright: © Institute of Research and Journals

| PDF |
Viewed - 46
| Published on 2018-03-29
   
   
IRAJ Other Journals
IJMAS updates
IJMAS -THANK YOU ALL FOR CONTRIBUTING YOUR PAPER TO IJMAS APRIL ISSUE. ALL AUTHORS ARE REQUESTED TO GET THEIR HARD COPY NOW.
The Conference World
Facebook

JOURNAL SUPPORTED BY